Mr. Amit Soni (DIN: 00057040), a highly experienced finance and management professional, has been appointed by the Board of Directors of Piramal Pharma Limited (a global pharmaceutical company) as a Non-Executive Independent Director for a term of five consecutive years, effective from December 8, 2025; the appointment is subject to the approval of the members at the ensuing Annual General Meeting, and he will contribute to the board’s strategic oversight, especially in financial matters.
